Back to results
US 8,030,443 B2Granted
Squamous cell carcinoma antigen-derived peptide binding to HLA-A24 molecule
AssigneeKurume University
InventorsKyogo Itoh, Mamoru Harada
Life of this patent
Estimating the term…
Abstract
Provided is a squamous cell carcinoma antigen derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of squamous cell carcinoma.
Claims2
An isolated peptide, which consists of the amino acid sequence of SEQ ID NO:
- 5 or 7.
An isolated peptide, comprising the amino acid sequence of SEQ ID NO:
- 5 or 7, wherein said isolated peptide is a peptide fragment of squamous cell carcinoma antigen having the amino acid sequence of SEQ ID NO:
- 11, capable of binding to an HLA-A24 molecule and recognized by the cellular immune system and wherein said peptide fragment consists of no more than 14 amino acid residues.
Dependencies are inferred from the claim text.